Global Breast Cancer Diagnosis Market - Forecasts From 2018 to 2023

November 2018 | 107 pages | ID: G3058BC6898EN
Knowledge Sourcing Intelligence LLP

Abstracts

The global Breast Cancer Diagnosis market is expected to reach US$6.333 billion by 2023 from US$4.142 billion in 2017 growing at a CAGR of 7.33%. Breast cancer is defined as the malignant tumour formed in the tissues of the breast and has emerged as the leading cancer among women across the globe. Several tests are carried out by the doctors to diagnose the site of initiation as well as to know if the cancer has metastasised to the other body parts or not. The breast cancer market is expected to show a robust growth during the given forecast period. The growth in the market may be attributed to the rising prevalence of the breast cancer across the globe. As per Centers for Disease Control and Prevention 242,476 new cases of Female Breast Cancer were reported in 2015 with 41,523 deaths in US. Technological advancements such as introduction of hybrid imaging technique will also be augmenting the market growth during the given time. However, dearth of the skilled and trained professionals might hamper the growth of the breast cancer diagnosis market during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global Breast Cancer Diagnosis market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Breast Cancer Diagnosis market.

Major industry players profiled as part of the report are among others.

Segmentation

By Diagnostic Techniques
Imaging
Surgical Biopsy
Lab Tests
By Cancer Type
BRCA Breast Cancer
ER & PR Breast Cancer
HER 2 Breast Cancer
EGFR Mutation Test Breast Cancer
Others
By End Users
Hospitals and Clinics
Cancer Research Centers
Diagnostic Laboratories
Ambulatory Surgical Centers
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. KEY FINDINGS OF THE STUDY

4. MARKET DYNAMICS

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. GLOBAL BREAST CANCER DIAGNOSIS MARKET FORECAST BY DIAGNOSTIC TECHNIQUES

5.1. Imaging
5.2. Surgical Biopsy
5.3. Lab Tests

6. GLOBAL BREAST CANCER DIAGNOSIS MARKET FORECAST BY CANCER TYPE

6.1. BRCA Breast Cancer
6.2. ER & PR Breast Cancer
6.3. HER 2 Breast Cancer
6.4. EGFR Mutation Test Breast Cancer
6.5. Others

7. GLOBAL BREAST CANCER DIAGNOSIS MARKET FORECAST BY END USER

7.1. Hospitals and Clinics
7.2. Cancer Research Centers
7.3. Diagnostic Laboratories
7.4. Ambulatory Surgical Centers

8. GLOBAL BREAST CANCER DIAGNOSIS FORECAST BY GEOGRAPHY

8.1. North America
  8.1.1. The U.S
  8.1.2. Canada
  8.1.3. Mexico
  8.1.4. Others
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. U.K.
  8.3.2. France
  8.3.3. Germany
  8.3.4. Italy
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. Saudi Arabia
  8.4.2. UAE
  8.4.3. Israel
  8.4.4. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. India
  8.5.3. Australia
  8.5.4. South Korea
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals

10. COMPANY PROFILES

10.1. Abbott
  10.1.1. Overview
  10.1.2. Financials
  10.1.3. Product and Services
  10.1.4. Recent Developments
10.2. Hologic Inc.
  10.2.1. Overview
  10.2.2. Financials
  10.2.3. Product and Services
  10.2.4. Recent Developments
10.3. F. Hoffmann-La Roche Ltd
  10.3.1. Overview
  10.3.2. Financials
  10.3.3. Product and Services
  10.3.4. Recent Developments
10.4. General Electric Company
  10.4.1. Overview
  10.4.2. Financials
  10.4.3. Product and Services
  10.4.4. Recent Developments
10.5. Thermo Fisher Scientific Inc.
  10.5.1. Overview
  10.5.2. Financials
  10.5.3. Product and Services
  10.5.4. Recent Developments
10.6. Koninklijke Philips N.V.
  10.6.1. Overview
  10.6.2. Financials
  10.6.3. Product and Services
  10.6.4. Recent Developments
10.7. Siemens AG
  10.7.1. Overview
  10.7.2. Financials
  10.7.3. Product and Services
  10.7.4. Recent Developments
10.8. FUJIFILM Holdings Corporation
  10.8.1. Overview
  10.8.2. Financials
  10.8.3. Product and Services
  10.8.4. Recent Developments
10.9. Illumina, Inc.
  10.9.1. Overview
  10.9.2. Financials
  10.9.3. Product and Services
  10.9.4. Recent Developments
10.10. Toshiba Corporation
  10.10.1. Overview
  10.10.2. Financials
  10.10.3. Product and Services
  10.10.4. Recent Developments